Gland Pharma Ltd

NSE :GLAND   BSE :543245  Sector : Pharmaceuticals
Buy, Sell or Hold GLAND? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

19 Apr
1763.60
(-0.05%)
18 Apr
1764.40
(0.84%)
16 Apr
1749.75
(-0.15%)
15 Apr
1752.30
(0.15%)
12 Apr
1749.65
(-2.39%)
10 Apr
1792.40
(-0.44%)
09 Apr
1800.35
(-3.19%)
08 Apr
1859.60
(5.99%)
05 Apr
1754.55
(-1.16%)
04 Apr
1775.10
(-0.70%)
03 Apr
1787.60
(-0.06%)
02 Apr
1788.70
(-1.38%)
01 Apr
1813.75
(-1.71%)
28 Mar
1845.25
(1.36%)
27 Mar
1820.50
(1.62%)
26 Mar
1791.45
(-0.16%)
22 Mar
1794.35
(2.36%)
21 Mar
1753.00
(3.07%)
20 Mar
1700.75
(-4.07%)
19 Mar
1772.90
(-0.76%)
18 Mar
1786.45
(-0.20%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Bearish
Medium Term Investors

Very Bearish
Long Term Investors

Bullish

Moving Averages

5 DMA
Bullish

1754.28

10 DMA
Bearish

1775.66

20 DMA
Bearish

1780.88

50 DMA
Bearish

1831.26

100 DMA
Bearish

1857.47

200 DMA
Bullish

1681.89


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 19, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1827.24 1803.47 1775.62 - -
R2 1803.47 1786.78 1771.61 1804.43 -
R1 1783.54 1776.46 1767.61 1785.46 1793.5
P 1759.77 1759.77 1759.77 1760.73 1764.75
S1 1739.84 1743.08 1759.59 1741.76 1749.8
S2 1716.07 1732.76 1755.59 1717.03 -
S3 1696.14 1716.07 1751.58 - -

Key Metrics

EPS

50.74

P/E

34.72

P/B

3.46

Dividend Yield

0%

Market Cap

29,048 Cr.

Face Value

1

Book Value

509.9

ROE

10.33%

EBITDA Growth

392.78 Cr.

Debt/Equity

0

Shareholding Pattern

  57.86% Total Promoter Holding
23.01% Mutual Fund Holdings
3.59% FIIs
13.32% Non Institution
1.21% Insurance Companies
0% Custodians
1.01% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Gland Pharma Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 999.8 823.95 1246.24 1426.58 1582.55
PROFIT 231.95 113.32 194.1 194.08 191.86
EPS 14.08 4.78 11.79 11.78 11.65

Gland Pharma Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 987.41 824.36 919.28 1051.78 1141.25
PROFIT 227.54 113.88 187.58 257.53 276.81
EPS 13.82 4.81 11.39 15.64 16.81

Profit & Loss (Figures in Rs. Crores)


Gland Pharma Ltd Profit & Loss


Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 2779.31 3871.15 4587.96 3911.98
PROFIT 759.87 996.94 1208.44 820.62
EPS 0 60.94 73.75 47.42

Gland Pharma Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 1076.01 1017.07 1375.14 1466.37 1735.4 2243.91 2779.31 3871.15 4587.96 3903.91
PROFIT 223.9 209.29 313.72 413.69 321.1 465.06 759.87 996.99 1208.94 815.38
EPS 190.4 133.53 202.39 267.01 207.24 291.65 49.88 60.95 73.78 47.11

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :
Share Capital 16.4716.4316.3615.5
Reserves Total 7,942.257,141.115,886.883,630.74
Equity Application Money00.0800
Total Shareholders Funds7,958.727,157.625,903.243,646.24
Unsecured Loans 4.454.7454.96
Total Debt4.454.7454.96
Other Liabilities1.731.731.732.66
Total Liabilities7,964.97,164.095,909.973,653.86
APPLICATION OF FUNDS :
Gross Block 2,294.962,081.321,430.71,347.81
Less: Accumulated Depreciation724.41579.13476.47379.71
Net Block1,570.551,502.19954.23968.1
Capital Work in Progress177.22190.75337.81188.47
Investments 0154.8700
Inventories 1,945.31,185.671,275.17756.28
Sundry Debtors 871.391,074.81670.97601.79
Cash and Bank Balance3,770.683,093.443,005.751,325.19
Loans and Advances 313.44343.3171.75163.03
Total Current Assets6,900.815,697.215,123.642,846.29
Current Liabilities 696.12539.02458.41329.93
Provisions 32.342.7553.8228.2
Total Current Liabilities & Provisions728.42581.77512.23358.13
Net Current Assets6,172.395,115.444,611.412,488.15
Deferred Tax Assets22.717.656.026.05
Deferred Tax Liability106.9295.4179.980.1
Net Deferred Tax-84.21-87.76-73.88-74.05
Other Assets128.96288.680.483.18
Total Assets7,964.97,164.095,909.973,653.85
Contingent Liabilities22.0712.7674.711.83
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 16.4716.4316.3615.515.515.515.515.4915.6711.76
Reserves Total 7,936.837,141.725,886.933,630.742,846.622,394.932,074.321,661.571,378.52821.89
Equity Application Money00.0800000000
Total Shareholders Funds7,953.37,158.235,903.293,646.242,862.122,410.432,089.821,677.061,394.19833.65
Secured Loans 000000090.07129.01158.62
Unsecured Loans 4.454.7454.965.495.926.3826.9737.4517.56
Total Debt4.454.7454.965.495.926.38117.04166.46176.18
Other Liabilities1.731.731.732.6615.238.1339.260.370.270.67
Total Liabilities7,959.487,164.75,910.023,653.862,882.812,454.482,135.461,794.471,560.921,010.5
APPLICATION OF FUNDS :
Gross Block 2,294.962,081.321,430.71,347.811,219.581,054.451,005.521,020.22820.49565.31
Less : Accumulated Depreciation 724.41579.13476.47379.71290.83211.81133.94232.34171.86105.57
Net Block 1,570.551,502.19954.23968.1928.75842.64871.58787.88648.63459.74
Capital Work in Progress177.22190.75337.81188.47123.16198.88161.15202.1192.08207.88
Investments 8.16163.030.5500000.170.170.05
Inventories 1,945.31,185.671,275.17756.28911.88512.83378.72367.08321.19306.36
Sundry Debtors 862.841,074.81670.97601.79506.1475.21417.87350.69169.31168.2
Cash and Bank Balance3,7673,085.83,005.21,325.19753.35651.14533.08273.23315.6377.1
Loans and Advances 313.2343.3171.73163.03186.14211.878.4880.9149.3532.92
Total Current Assets6,888.345,689.575,123.072,846.292,357.461,850.981,408.151,071.9855.48584.58
Current Liabilities 698.17538.93458.34329.93518.27363.11250.7219.68154.38235.84
Provisions 31.3242.7553.8228.213.8915.012.237.120.50.92
Total Current Liabilities & Provisions729.49581.68512.16358.13532.15378.12252.93226.8154.89236.76
Net Current Assets6,158.855,107.894,610.92,488.151,825.311,472.861,155.22845.1700.6347.82
Deferred Tax Assets22.717.656.026.051.631.290.9400.390.67
Deferred Tax Liability106.9295.4179.980.1109.2697.0486.3165.0442.7339.99
Net Deferred Tax-84.21-87.76-73.88-74.05-107.63-95.75-85.37-65.04-42.34-39.32
Other Assets128.92288.680.483.18113.2235.8432.8624.2561.7834.34
Total Assets7,959.487,164.75,910.013,653.852,882.812,454.472,135.441,794.461,560.911,010.51
Contingent Liabilities22.0712.7674.711.8321.17083.9946.77.660

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...1,054.58
Depreciation146.74
Interest (Net)-173.13
P/L on Sales of Assets0.08
Prov. and W/O (Net)8.54
P/L in Forex2.36
Total Adjustments (PBT and Ext...38.19
Operating Profit before Workin...1,092.77
Trade and 0ther Receivables144
Inventories-759.63
Trade Payables120.98
Loans and Advances0.33
Total Adjustments (OP before W...-417.94
Cash Generated from/(used in) ...674.83
Direct Taxes Paid-310.87
Total Adjustments(Cash Generat...-310.87
Cash Flow before Extraordinary...363.97
Net Cash from Operating Activi...363.97
Purchased of Fixed Assets-223.12
Sale of Fixed Assets0.14
Purchase of Investments-469.98
Sale of Investments627.7
Interest Received160.6
Net Cash used in Investing Act...1,211.19
Proceeds from Issue of shares ...21.5
Of the Long Tem Borrowings-0.11
Of Financial Liabilities-0.18
Interest Paid-6.29
Net Cash used in Financing Act...14.92
Net Profit before Tax and Extr...1,048.4
Depreciation146.74
Interest (Net)-173.13
P/L on Sales of Assets0.08
P/L on Sales of Invest-2.85
Prov. and W/O (Net)8.54
P/L in Forex1.54
Total Adjustments (PBT and Ext...37.38
Operating Profit before Workin...1,085.78
Trade and 0ther Receivables152.55
Inventories-759.63
Trade Payables123.13
Loans and Advances0.33
Total Adjustments (OP before W...-407
Cash Generated from/(used in) ...678.78
Direct Taxes Paid-310.89
Total Adjustments(Cash Generat...-310.89
Cash Flow before Extraordinary...367.89
Net Cash from Operating Activi...367.89
Purchased of Fixed Assets-223.12
Sale of Fixed Assets0.14
Purchase of Investments-469.98
Sale of Investments627.7
Interest Received160.64
Net Cash used in Investing Act...1,211.22
Proceeds from Issue of shares ...21.5
Of the Long Tem Borrowings-0.11
Of Financial Liabilities-0.18
Interest Paid-6.29
Net Cash used in Financing Act...14.92

Company Details

Registered Office
AddressSy No 143-148 150&151 Nr Gandi,
X Roads D P Pally Dundigal
CityHyderabad
StateTelangana
Pin Code500043
Tel. No.91-40-30510999
Fax. No.91-40-30510800
Emailinvestors@glandpharma.com
Internethttp://www.glandpharma.com
Registrars
AddressSy No 143-148 150&151 Nr Gandi
CityHyderabad
StateTelangana
Pin Code500043
Tel. No.91-40-30510999
Fax. No.91-40-30510800
Emailinvestors@glandpharma.com
Internethttp://www.glandpharma.com
Management
Name Designation
Yiu Kwan Stanley LauChairman & Independent Directo
SRINIVAS SADUManaging Director & CEO
QIYU CHENNon-Exec & Non-Independent Dir
UDO JAHANNES VETTERNon-Exec & Non-Independent Dir
C S N MurthyIndependent Director
ESSAJI GOOLAM VAHANVATIIndependent Director
Naina Lal KidwaiIndependent Director
Jia Ai (Allen) ZhangNon-Exec & Non-Independent Dir
Yao FangNon-Exec & Non-Independent Dir